PRECIGEN Investors

Events & Presentations

Events & Presentations

Upcoming Events

Jun 04, 2021 at 9:00 AM EDT
Trial-in-progress poster presentation of the PRGN-2009 abstract "First-in-human Phase I/II trial of PRGN-2009 vaccine as monotherapy or with bintrafusp alfa in patients with recurrent/metastatic (R/M) human papillomavirus (HPV)-associated cancers (HPVC) and as neoadjuvant/induction therapy in locoregionally advanced (LA) HPV oropharyngeal (OP) and sinonasal (SN) squamous cell cancer (SCC)." The poster presentation will be presented by Charalampos S. Floudas, MD, DMSc, MS, Assistant Research Physician, Genitourinary Malignancies Branch at the Center for Cancer Research at the National Cancer Institute (NCI). Presented in Poster Sessions: Head and Neck Cancer.
Read More
Jun 10, 2021 at 5:05 PM - 5:20 PM EDT
Oral presentation of the AG019 abstract "Lactococcus lactis producing Proinsulin and IL-10 therapy increases Antigen Specific Regulatory T-cells in Monotherapy and in Combination with an anti-CD3 Monoclonal Antibody (Teplizumab) in newly diagnosed T1D patients." The abstract will be presented by Kevan Herold, MD, CNH Long Professor of Immunobiology and of Medicine (Endocrinology) at the Yale School of Medicine. Presented in Thematic Sessions: Human Microbiome.
Read More

Past Events

Dec 07, 2020 at 7:00 AM - 3:30 PM PST
Precigen presented abstract entitled "A Phase 1/1b Safety Study of PRGN-3006 UltraCAR-T in Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndrome." (Abstract 2864)
Read More
Jun 22, 2020

Tim Chan, PhD, Senior Director, Immuno-Oncology of Precigen presented the poster “PRGN-3005 UltraCAR-T™: Multigenic CAR-T Cells Generated Using Non-viral Gene Delivery and Rapid Manufacturing Process for the Treatment of Ovarian Cancer”. (Abstract 6593)

Read More